2016 Publications

Aellah, G; Chantler, T; Geissler, PW; (2016) Global Health Research in an Unequal World: Ethics Case Studies from Africa. Wallingford: CABI Publishing. ISBN 1786390043


Alshaikhahmed, K; Roy, P; (2016) Generation of virus-like particles for emerging epizootic haemorrhagic disease virus: Towards the development of safe vaccine candidates. Vaccine, 34 (8). pp. 1103-8. ISSN 0264-410X DOI:10.1016/j.vaccine.2015.12.069


Atkins, K; van Hoek, AJ; Watson, C; Baguelin, M; Choga, L; Patel, A; Raj, T; Jit, M; Griffiths, U; (2016) Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot. BMJ Open, 6 (2). e009739. ISSN 2044-6055 DOI: 10.1136/bmjopen-2015-009739


Awine, T; Belko, MM; Oduro, AR; Oyakhirome, S; Tagbor, H; Chandramohan, D; Milligan, P; Cairns, M; Greenwood, B;Williams, JE; (2016) The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine. Malar J, 15 (1). p. 46. ISSN 1475-2875 DOI: 10.1186/s12936-016-1094-z


Brotherton, JM; Jit, M; Gravitt, PE; Brisson, M; Kreimer, AR; Pai, SI; Fakhry, C; Monsonego, J; Franceschi, S; (2016)Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines. International journal of cancer Journal international du cancer. ISSN 0020-7136 DOI: 10.1002/ijc.30063


Casey, WT; Spink, N; Cia, F; Collins, C; Romano, M; Berisio, R; Bancroft, GJ; McClean, S; (2016) Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Vaccine, 34 (23). pp. 2616-21. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.03.088


Champion, OL; Gourlay, LJ; Scott, AE; Lassaux, P; Conejero, L; Perletti, L; Hemsley, C; Prior, J; Bancroft, G; Bolognesi, M;+1 more… (2016) Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.02.038


Dockrell, HM; (2016) Towards new TB vaccines: what are the challenges? Pathog Dis, 74 (4). ftw016. ISSN 2049-632X DOI: 10.1093/femspd/ftw016


Eggo, RM; Scott, JG; Galvani, AP; Meyers, LA; (2016) Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model. Proceedings of the National Academy of Sciences of the United States of America, 113 (8). pp. 2194-9. ISSN 0027-8424 DOI: 10.1073/pnas.1518677113


Erondu, N; (2016) Evaluating communicable disease surveillance in resource-poor settings: A new approach applied to meningitis surveillance in Chad. PhD thesis, London School of Hygiene & Tropical Medicine.


Flasche, S; Jit, M; Rodriguez-Barraquer, I; Coudeville, L; Recker, M; Koelle, K; Milne, G; Hladish, TJ; Cummings, DAT; Dorigatti, I; Laydon, DJ; Espana, G; Kelso, J; +7 more… (2016) The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study PLOS Medicine. DOI:10.1371/journal.pmed.1002181


Fitchett, EJA; Seale,AC; Vergnano, S; Sharland, M; Heath, PT; Saha, SK; Agarwal, R; +17more Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infectious Diseases 16(10) e202-213. DOI: 10.1016/S1473-3099(16)30082-2


Fragaszy, EB; Warren-Gash, C; Wang, L; Copas, A; Dukes, O; Edmunds, WJ; Goonetilleke, N; Harvey, G; Johnson, AM;Kovar, J; +11 more… (2016) Cohort Profile: The Flu Watch Study. International journal of epidemiology. ISSN 0300-5771 DOI: 10.1093/ije/dyv370


Gallagher, KE; Kadokura, E; Eckert, LO; Miyake, S; Mounier-Jack, S; Aldea, M; Ross, DA; Watson-Jones, D; (2016)Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review. BMC Public Health, 16 (1). p. 172. ISSN 1471-2458 DOI: 10.1186/s12889-016-2845-z


Greenwood, B; Doumbo, OK; (2016) Implementation of the malaria candidate vaccine RTS,S/AS01. Lancet. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)00807-7


Greenwood, B; Tine, R; (2016) Primaquine to stop transmission of falciparum malaria. The Lancet infectious diseases. ISSN 1473-3099 DOI: 10.1016/S1473-3099(15)00550-2


Hammitt, LL; Crane, RJ; Karani, A; Mutuku, A; Morpeth, SC; Burbidge, P; Goldblatt, D; Kamau, T; Sharif, S; Mturi, N; +1 more… (2016) Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study. Lancet Glob Health, 4 (3). e185-94. ISSN 2214-109X DOI: 10.1016/S2214-109X(15)00316-2


Herlihy, N; Hutubessy, R; Jit, M; (2016) Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries. Health affairs (Project Hope), 35 (2). pp. 227-34. ISSN 0278-2715 DOI:10.1377/hlthaff.2015.1411


Howard, N; Mounier-Jack, S; Gallagher, KE; Kabakama, S; Griffiths, UK; Feletto, M; LaMontagne, DS; Burchett, HE;Watson-Jones, D; (2016) The value of demonstration projects for new interventions: the case of human papillomavirus vaccine introduction in low and middle-income countries. Human vaccines & immunotherapeutics. pp. 1-3. ISSN 2164-5515 DOI: 10.1080/21645515.2016.1178433


Kaur, H; Clarke, S; Lalani, M; Phanouvong, S; Guérin, P; McLoughlin, A; Wilson, BK; Deats, M; Plançon, A; Hopkins, H; +2 more… (2016) Fake anti-malarials: start with the facts. Malar J, 15 (1). p. 86. ISSN 1475-2875 DOI: 10.1186/s12936-016-1096-x


Kieny, MP; Longini, IM; Henao-Restrepo, AM; Watson, CH; Egger, M; Edmunds, WJ; (2016) Changes in the primary outcome in Ebola vaccine trial – Authors’ reply. Lancet, 387 (10027). pp. 1509-1510. ISSN 0140-6736 DOI: 10.1016/S0140-6736(16)00686-3


Kucharski, AJ; Eggo, RM; Watson, CH; Camacho, A; Funk, S; Edmunds, WJ; (2016) Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease. Emerging infectious diseases, 22 (1). pp. 105-108. ISSN 1080-6040 DOI:10.3201/eid2201.151410


Langan, SM; Thomas, SL; Smeeth, L; Margolis, DJ; Nitsch, D; (2016) Zoster vaccination is associated with a reduction of zoster in elderly patients with chronic kidney disease. Nephrology, dialysis, transplantation . ISSN 0931-0509 DOI:10.1093/ndt/gfv432


Larson, HJ; Van Damme, P; FitzSimons, D; (2016) A hepatitis-free future: strategy first, then pricing. The Lancet infectious diseases, 16 (4). pp. 399-400. ISSN 1473-3099 DOI: 10.1016/S1473-3099(16)00126-2


Leite, A; Andrews, NJ; Thomas, SL; (2016) Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods. Pharmacoepidemiology and drug safety, 25 (3). pp. 225-37. ISSN 1053-8569 DOI: 10.1002/pds.3966


Licciardi, PV; Toh, ZQ; Clutterbuck, EA; Balloch, A; Marimla, RA; Tikkanen, L; Lamb, KE; Bright, KJ; Rabuatoka, U;Tikoduadua, L; +7 more… (2016) No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine. The Journal of allergy and clinical immunology, 137 (6). 1772-1779.e11. ISSN 0091-6749 DOI: 10.1016/j.jaci.2015.12.1303


Mackenzie, GA; Hill, PC; Jeffries, DJ; Hossain, I; Uchendu, U; Ameh, D; Ndiaye, M; Adeyemi, O; Pathirana, J; Olatunji, Y;+32 more… (2016) Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. The Lancet infectious diseases, 16 (6). pp. 703-11. ISSN 1473-3099 DOI: 10.1016/S1473-3099(16)00054-2


Mesher, D; Panwar, K; Thomas, SL; Beddows, S; Soldan, K; (2016) Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study. BMJ Open, 6 (2). e009915. ISSN 2044-6055 DOI: 10.1136/bmjopen-2015-009915


Modjarrad, K; Giersing, B; Kaslow, DC; Smith, PG; Moorthy, VS; WHO RSV Vaccine Consultation Expert Group; , COLLABORATORS; Arora, NK; Bont, L; Campbell, H; +15 more… (2016) WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine, 34 (2). pp. 190-7. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.05.093


Monath, TP; Woodall, JP; Gubler, DJ; Yuill, TM; Mackenzie, JS; Martins, RM; Reiter, P; Heymann, DL; (2016) Yellow fever vaccine supply: a possible solution. Lancet, 387 (10028). pp. 1599-1600. ISSN 0140-6736 DOI: 10.1016/S0140-6736(16)30195-7


Nguipdop-Djomo, P; Heldal, E; Rodrigues, LC; Abubakar, I; Mangtani, P; (2016) BCG vaccination: a long-lasting protection against tuberculosis? – Authors’ reply. The Lancet infectious diseases, 16 (4). pp. 408-9. ISSN 1473-3099 DOI:10.1016/S1473-3099(16)00134-1


Nguipdop-Djomo, P; Heldal, E; Rodrigues, LC; Abubakar, I; Mangtani, P; (2016) Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. The Lancet infectious diseases, 16 (2). pp. 219-26. ISSN 1473-3099 DOI: 10.1016/S1473-3099(15)00400-4


Penny, MA; Verity, R; Bever, CA; Sauboin, C; Galactionova, K; Flasche, S; White, MT; Wenger, EA; Van de Velde, N;Pemberton-Ross, P; +6 more… (2016) Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet, 387 (10016). pp. 367-75. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)00725-4


Rhodes, SJ; Knight, GM; Fielding, K; Scriba, TJ; Pathan, AA; McShane, H; Fletcher, H; White, RG; (2016) Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.Tuberculosis (Edinburgh, Scotland), 96. pp. 37-43. ISSN 1472-9792 DOI: 10.1016/j.tube.2015.10.002


Roca, A; Oluwalana, C; Bojang, A; Camara, B; Kampmann, B; Bailey, R; Demba, A; Bottomley, C; D’Alessandro, U; (2016) Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial. Clinical microbiology and infection , 22 (6). 565.e1-9. ISSN 1198-743X DOI: 10.1016/j.cmi.2016.03.005


Seale, AC; Davies, MR; Anampiu, K; Morpeth, SC; Nyongesa, S; Mwarumba, S; Smeesters, PR; Efstratiou, A; Karugutu, R;Mturi, N; +5 more… (2016) Invasive Group A Streptococcus Infection among Children, Rural Kenya. Emerging infectious diseases, 22 (2). pp. 224-232. ISSN 1080-6040 DOI: 10.3201/eid2202.151358


Steer, AC; Carapetis, JR; Dale, JB; Fraser, JD; Good, MF; Guilherme, L; Moreland, NJ; Mulholland, EK; Schodel, F;Smeesters, PR; (2016) Status of vaccine research and development of vaccines for Streptococcus pyogenes. Vaccine, 34 (26). pp. 2953-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2016.03.073


Sullivan, RT; Ssewanyana, I; Wamala, S; Nankya, F; Jagannathan, P; Tappero, JW; Mayanja-Kizza, H; Muhindo, MK;Arinaitwe, E; Kamya, M; +5 more… (2016) Erratum to: B cell sub-types following acute malaria and associations with clinical immunity. Malar J, 15 (1). p. 188. ISSN 1475-2875 DOI: 10.1186/s12936-016-1236-3


Sullivan, RT; Ssewanyana, I; Wamala, S; Nankya, F; Jagannathan, P; Tappero, JW; Mayanja-Kizza, H; Muhindo, MK;Arinaitwe, E; Kamya, M; +6 more… (2016) B cell sub-types following acute malaria and associations with clinical immunity.Malar J, 15 (1). p. 139. ISSN 1475-2875 DOI: 10.1186/s12936-016-1190-0


Torres-Rueda, S; Rulisa, S; Burchett, HE; Mivumbi, NV; Mounier-Jack, S; (2016) HPV vaccine introduction in Rwanda: Impacts on the broader health system. Sexual & reproductive healthcare , 7. pp. 46-51. ISSN 1877-5756 DOI:10.1016/j.srhc.2015.11.006


Turner, HC; Truscott, JE; Fleming, FM; Hollingsworth, TD; Brooker, SJ; Anderson, RM; (2016) Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses. The Lancet infectious diseases, 16 (7). pp. 838-46. ISSN 1473-3099 DOI: 10.1016/S1473-3099(15)00268-6


Vandebosch, A; Mogg, R; Goeyvaerts, N; Truyers, C; Greenwood, B; Watson-Jones, D; Herrera-Taracena, G; Parys, W;Vangeneugden, T; (2016) Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges. Clinical trials (London, England), 13 (1). pp. 57-65. ISSN 1740-7745 DOI: 10.1177/1740774515621059


Vynnycky, E; Yoshida, LM; Huyen, DT; Trung, ND; Toda, K; Cuong, NV; Thi Hong, D; Ariyoshi, K; Miyakawa, M; Moriuchi, H;+5 more… (2016) Modeling the impact of rubella vaccination in Vietnam. Human vaccines & immunotherapeutics, 12 (1). pp. 150-8. ISSN 2164-5515 DOI: 10.1080/21645515.2015.1060380


Yeung, MP; Lam, FL; Coker, R; (2016) Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review. Journal of public health (Oxford, England). ISSN 1741-3842 DOI: 10.1093/pubmed/fdv194


Zak, DE; Penn-Nicholson, A; Scriba, TJ; Thompson, E; Suliman, S; Amon, LM; Mahomed, H; Erasmus, M; Whatney, W;Hussey, GD; +136 more… (2016) A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet, 387 (10035). pp. 2312-22. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)01316-1


de la Hoya, M; Soukarieh, O; López-Perolio, I; Vega, A; Walker, LC; van Ierland, Y; Baralle, D; Santamariña, M; Lattimore, V;Wijnen, J; +65 more… (2016) Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Human molecular genetics. ISSN 0964-6906 DOI: 10.1093/hmg/ddw094